Navigation Links
Carlyle-ManorCare Facing New Federal Charges for Breaking the Law: Interrogating, Threatening, Retaliating Against Nursing Home Workers for Trying to Form a Union
Date:8/27/2008

PHILADELPHIA, Aug. 27 /PRNewswire-USNewswire/ -- The National Labor Relations Board issued new charges against Carlyle-ManorCare in Easton, Penn. yesterday. Workers from the Easton facility had filed a series of charges with the NLRB against ManorCare for interrogating, threatening, retaliating against workers, and attempting to bribe workers to stifle union activity. "ManorCare doesn't want to make real improvements. They're trying to buy us off by offering money or benefits to people so that we will back down. But what we really need is a voice to stand up for ourselves and our residents. What we want is to join together and form our union," said Karen Delabar, a Certified Nurse Assistant.

Like other Carlyle-ManorCare workers nationwide, caregivers in Easton have been struggling to form a union for more than a year.

This isn't the first time that workers have filed Federal charges against Carlyle-ManorCare. Other charges have been filed against the Easton facility, and workers at HCR Manor Care-Bethlehem filed a Federal charge with the Labor Board last week for three separate incidents of illegally threatening and interrogating workers about union activity. The Board has not yet issued a complaint on that charge.

The NLRB decided to combine the complaint yesterday with existing charges against ManorCare-Easton. Previous charges include that ManorCare interrogated employees, confiscated union literature, and retaliated against a worker for pro-union activity. Now, the Labor Board has added additional charges to the complaint accusing Manor Care of interrogating and threatening employees and granting employees benefits to attempt to stifle the workers attempts to form a union. The combined complaint will be heard Sept. 10 and 11.

Carlyle-ManorCare workers and SEIU Healthcare members are calling on ManorCare to give workers a free and fair choice about whether or not to join a union, and stop its campaign of harassment and intimidat
'/>"/>

SOURCE SEIU Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. JUVA Skin & Laser Center Introduces Affirm CO2 to New York City Laser Resurfacing Clients
2. Laser Resurfacing Produces Long-Term Results
3. Patient Who Was Raped by Doctor Is Now Facing Motion for Sanctions Being Sought by Health System
4. John McCains Record on Helping Families Facing Medical Bankruptcy: Bankrupt.
5. DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
6. National Family Month 2008 Focuses on Top Issues Facing Kids and Families Today
7. DeepFX(TM) and ActiveFX(TM) Fractional Resurfacing Featured at Annual Meeting of The American Society Of Aesthetic Plastic Surgery
8. Cengage Learning Survey Reveals College Instructor Views on Challenges Facing First-Year Students
9. The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing
10. Report Lists Key Policy Questions Facing State, National Health Reform
11. Its National Patient Recognition Week - Heres How You Can Do Something Special for Someone Facing Illness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...earchers, from the School of Medicine,s Department...ys by which products of lipid peroxidation and som...abolized. The pathways were identified by a combin.... The findings shed new light on the mechanism of ... also known as "the date rape drug." The manuscrip...
(Date:12/4/2009)...immediately or 3 weeks later, study shows , ... surgical repair or reconstruction of multiple-lig..., a new study has found. , Multiple-ligament kn...s that can occur in high-impact car crashes or in ...y to repair these injuries hasn,t been definitivel...
(Date:12/4/2009)...s Historic Effort but Points out Potential Risk if...ealth Care Reform ,, NEW YORK, Dec. 4 /PRNews...edicine today published a Perspective opinion pi...Irwin Redlener, M.D., president, Children,s Health...reparedness and Professor of Clinical Population &...
(Date:12/4/2009)...ookah, research shows , , FRIDAY, Dec. 4... cigarettes for smoking tobacco, researchers say. ...co with a water pipe inhale carbon monoxide and ni...and nicotine addiction. , The study included 31...ng a water pipe and a single cigarette. After each...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- When the spread of H1N1 f... of Health Services needed to get more information...n Sonic Foundry, Inc. (Nasdaq: SOFO ), the reco... knowledge management, for a live webinar in which...h Services, will share how in-house webcasting rel...
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
...o be the most powerful indicator of heart disease....reased levels of total amount cholesterol in blood...tein)or 'bad' cholesterol and HDL(High-Density Lip...d molecule called// apolipoprotein, which they bel...
...s the world over, with India being touted as the "...erious diseases that diabetics can be affected wit...the deterioration of nerves in the body. A diabeti...abetes will develop// neuropathy. A study by ...
...uing the field of medicine and patients are now de... medical error happens. However, doctors are often...ey do not care. In fact, doctors confessed to bein...ng patients, doctors, and// patients and doctors t...
...eceived a patient, a two-month-old baby with white...are disease caused due to a deficiency of lipoprot... 10 million children. Doctors said that the baby w...his condition could be either due to// ‘familial l...
...a common genetic mutation called C150T transition ...scovering a "fountain of youth". This genetic muta...lood cells, in a study of a group of 52 Italian ce...he age// of 99. Mitochondria are so-called "o...
...ersity of Rochester, New York suggests that the ac...mmatory and anti-coagulant properties,which until ...also help reduce the damage caused by stroke. Rese...ng apoptosis, a form of programmed cell death. The...
Other Medicine News:
(Date:12/4/2009)...c. 4 Suneva Medical, a privately-h...ced the appointment of Philip Ranker as Vice Presi...r. Ranker will lead all Suneva Medical,s general a...ounting, IT, IR, administration and human resource...agement team. ,, "One of my key objectives as ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawf...n (PSA) recurrence from the additional analysis of...te in a Phase III pivotal study of FIRMAGON® ...olide in prostate cancer patients during the first...received FIRMAGON 240/80 mg/month had a recurrence...
(Date:12/3/2009)... Allen Medical Systems, ...RC ), today announced the launch of its new Allen ...business website www.AllenAmatech.com . ,, ... identity and includes an online version of the ne...design specifications for the products. "We hope t...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 1Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 3AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 1AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 2AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 3Hartford grants increase support for geriatric social work training 49209 1Hartford grants increase support for geriatric social work training 49209 2Hartford grants increase support for geriatric social work training 49209 3
...ne in the Treatment of Patients with Relapsed/Ref...ented Tomorrow, Tuesday, June 3rd at 12:0...rmaceuticals,Inc. (Nasdaq: KERX ) today announced...ave been selected for both poster presentation and...al Oncology Meeting,currently taking place in Chic...
...erican Society of Clinical Oncology (ASCO),annual ...vival vs. external c...c.,(Nasdaq: IDMI ) today announced follow-up resu...t the product candidate was well tolerated, induce...sponses, and showed a,positive survival trend in H...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 5IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 2IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 3IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 4
Disposable Lacrimal Dilators
Reusable Double Dilators
Skin Tone External Eyelid Weights
Contour Design Eyelid Implants (Gold)
Medicine Products: